Atara Biotherapeutics Inc Logo Image

Atara Biotherapeutics Inc

Atara Biotherapeutics Inc Banner Image

Most Recent Annual Report

2014 Form 10K, 2015 Annual Report

Atara Biotherapeutics Inc

Atara Biotherapeutics Inc does not currently have any hardcopy reports available on AnnualReports.com. Click the button below to be notified when hardcopies become available.



Archived Annual Reports

  • Atara Biotherapeutics Inc

About Atara Biotherapeutics Inc

51-200 Employees
Based in Westlake Village, California

Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors that is in a Phase I clinical trial; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in South San Francisco, California.

Ticker:
ATRA
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol